Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
Hemogenyx Pharmaceuticals PLC and its subsidiary is a preclinical-stage biotechnology company focused on the discovery, development, and commercialization of novel therapies and treatments for blood diseases, like leukemia and lymphoma. The company's technologies aim to change the way in which bone marrow/hematopoietic stem cell transplants are performed and improve their efficacy.
| Last: | $2.33 |
|---|---|
| Change Percent: | 0.0% |
| Open: | $2.33 |
| Close: | $2.33 |
| High: | $2.33 |
| Low: | $2.33 |
| Volume: | 3,647 |
| Last Trade Date Time: | 07/23/2025 12:20:37 pm |
| Market Cap: | $74,085,821 |
|---|---|
| Float: | 3,036,298 |
| Insiders Ownership: | 12.2% |
| Institutions: | |
| Short Percent: | N/A |
| Industry: | Biotechnology & Life Sciences |
| Sector: | Healthcare |
| Website: | https://www.hemogenyx.com |
| Country: | GB |
| City: | London |
Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
**MWN-AI FAQ is based on asking OpenAI questions about Hemogenyx Pharmaceuticals (OTCMKTS: HOPHF).
Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.
Get instant news alerts to your mobile device as soon as the news hits the wire. Simply add a stock symbol to your portfolio and our service will alert you anytime there is news.
